These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8301016)
1. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus. Kucharz EJ; Sierakowski SJ; Goodwin JS Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):515-23. PubMed ID: 8301016 [TBL] [Abstract][Full Text] [Related]
2. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689 [TBL] [Abstract][Full Text] [Related]
3. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus. Sierakowski S; Kucharz EJ Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032 [TBL] [Abstract][Full Text] [Related]
4. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. Vassilopoulos D; Kovacs B; Tsokos GC J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273 [TBL] [Abstract][Full Text] [Related]
5. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm. Kammer GM J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173 [TBL] [Abstract][Full Text] [Related]
6. T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2. Draeger AM; Swaak AJ; van den Brink HG; Aarden LA Clin Exp Immunol; 1986 Apr; 64(1):80-7. PubMed ID: 3488149 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus. Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027 [TBL] [Abstract][Full Text] [Related]
8. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419 [TBL] [Abstract][Full Text] [Related]
9. Defective expression of p70/75 interleukin 2 receptor in T cells from patients with systemic lupus erythematosus: a possible defect in the process of increased intracellular calcium leading to p70/75 expression. Saiki O; Tanaka T; Kishimoto S J Rheumatol; 1990 Oct; 17(10):1303-7. PubMed ID: 2254888 [TBL] [Abstract][Full Text] [Related]
10. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. Fujii Y; Fujii K; Tanaka Y Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347 [TBL] [Abstract][Full Text] [Related]
11. [Cytokine production in patients with systemic lupus erythematosus]. Müzes G; González-Cabello R; Van Vien C; Fehér J; Gergely P Orv Hetil; 1991 Sep; 132(36):1971-4. PubMed ID: 1923468 [TBL] [Abstract][Full Text] [Related]
12. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124 [TBL] [Abstract][Full Text] [Related]
13. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Perl A; Gergely P; Banki K Int Rev Immunol; 2004; 23(3-4):293-313. PubMed ID: 15204090 [TBL] [Abstract][Full Text] [Related]
15. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens. Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744 [TBL] [Abstract][Full Text] [Related]
16. Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features. Fujii Y; Fujii K; Iwata S; Suzuki K; Azuma T; Saito K; Tanaka Y Clin Immunol; 2006 Jun; 119(3):297-306. PubMed ID: 16503201 [TBL] [Abstract][Full Text] [Related]
17. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637 [TBL] [Abstract][Full Text] [Related]
19. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus]. Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of interleukin 2 in SLE T cells. Tenbrock K; Tsokos GC Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]